Sponsored Content
Japanese Life Sciences Corporation Invests More Than 100 Million Euros in Vienna
Sponsored Content
The Japanese life sciences company Takeda Pharmaceutical Company Limited is investing more than 100 million euros in a new building in Seestadt, Vienna. Read about the massive investment and see a picture of what it is supposed to look like upon completion.



The Japanese life sciences company Takeda is investing over 100 million euros in a technically and ecologically optimized new building for biopharmaceutical research and development in Seestadt, Vienna.
This is the largest investment in research and development by the company in Austria, which has been operating at the site for almost 70 years. …
or Log In
Sponsored Content
Sponsored Content
Sponsored Content
Fast News Search
Related News
Budapest Office Property "BudaPart Gate" Acquired by S-Immo (November 15, 2021)
Südbahnhotel am Semmering: Former Grand Hotel Has New Owner (November 5, 2021)
Infineon Opened €1.6 Billion High-tech Chip Factory in Villach (October 20, 2021)
Sponsored Content
Read More
Vienna City Government - Magistrat der Stadt Wien, Vienna Business Agency, Vienna, Unicredit, Tokyo, Takeda Pharmaceutical Company Limited, Sustainability, Research and Development, Pharmaceutical Industry, Michael Ludwig, Manfred Rieger, Life Sciences Industry, Japan, Investing in Austria, Healthcare Industry, Health Industry, Employment, Christophe Weber, Christoph Nagel, Bank Austria
Featured